DC Field | Value | Language |
dc.contributor.author | Şciuca, S. | |
dc.date.accessioned | 2020-03-22T13:46:32Z | |
dc.date.available | 2020-03-22T13:46:32Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | ŞCIUCA, S. Aprecierea clinică a medicaţiei mucolitice cu Flavamed la copiii cu maladii bronhopulmonare cronice. In: Curierul Medical. 2009, nr. 2(308), pp. 6-7. ISSN 0130-1535. | en_US |
dc.identifier.issn | 0130-1535 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/7745 | |
dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2016/09/50.pdf | |
dc.description | Catedra Pediatrie, Facultatea Rezidenţiat, USMF „Nicolae Testemiţanu” | en_US |
dc.description.abstract | The study showed clinical effectiveness of Flavamed (Ambroxol) in the treatment of children with bronchopulmonary diseases in various forms and it is recommended for patients with chronic bronchitis and cystic fibrosis. In mucoviscidosis with bronchopulmonary affectation treatement with mucolitic medication is successful in the reestablishment of the permeability of the bronchial tree. Because of the superiority of Ambroxol to other secretolitic and expectorant drugs it can be used in the continuing of children with mucoviscidosis during the rehabilitation period. | en_US |
dc.description.abstract | Муколитическая терапия Флавамедом (Амброксолом) была включена в лечение детей с хроническими бронхитами и муковискозом. Исследования показали эффективность Флавамеда при различных формах бронхопневмонии. Муколитическое действие Флавамеда предотвращает накопление слизи и восстанавливает проходимость бронхиального дерева, что позволяет рекомендовать его для широкого применения у детей с бронхитом, муковискозом и фиброзным альвеолитом. | |
dc.language.iso | ro | en_US |
dc.publisher | The Scientific Medical Association of the Republic of Moldova | en_US |
dc.relation.ispartof | Curierul Medical | |
dc.subject | Flavamed | en_US |
dc.subject | bronhopulmonary disease | en_US |
dc.subject.mesh | Lung Diseases, Obstructive--drug therapy | en_US |
dc.subject.mesh | Expectorants--therapeutic use | en_US |
dc.subject.mesh | Lung Diseases, Obstructive | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Flavamed--therapeutic use | en_US |
dc.title | Aprecierea clinică a medicaţiei mucolitice cu Flavamed la copiii cu maladii bronhopulmonare cronice | en_US |
dc.title.alternative | Clinical evaluation of mucolytic therapy with Flavamed for children with chronic bronchopulmonary diseases | |
dc.title.alternative | Клиническая оценка муколитической терапии Флавомедом у детей с хроническими бронхо-легочными заболеваниями | |
dc.type | Article | en_US |
Appears in Collections: | Curierul Medical, 2009, Vol. 308, Nr. 2
|